GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Long-Term Deferred Tax of $426000.0 for Q1 2021, up 954.46% sequentially from $40400.0 in Q4 2020.

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $426000.0 for Q1 2021.

In Q1 2021, Long-Term Deferred Tax changed N/A year-over-year to $426000.0; the TTM figure through Mar 2021 stood at $426000.0 (changed N/A YoY), while the FY2020 annual figure was $40400.0, changed N/A from the prior year.
Long-Term Deferred Tax improved to $426000.0 in Q1 2021, from $40400.0 in the prior quarter.
Over the last five years, Long-Term Deferred Tax for WGS reached as high as $426000.0 in Q1 2021 and fell as low as $12000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	GeneDx Holdings	2.10 Bn	1.93 Bn	68.21 Mn

Download Data